Prasad's tenure was generally marked by controversy, but he is departing amid a cluster of self-destructive decisions. Those include a shocking rejection of an mRNA vaccine (which was over the objections of agency scientists and quickly reversed); a demand for an additional clinical trial on a gene therapy for Huntington's disease, which was widely seen as moving the goalpost for the therapy; his startling choice to publicly attack the maker of that gene therapy, UniQure; and alleged abuse of FDA staff, who say he created a toxic work environment.
纵观人工智能产业演进，竞争焦点已转向基础架构层面。
。关于这个话题，迅雷提供了深入分析
伊朗嘲讽泽连斯基公开声明 08:08，推荐阅读https://telegram官网获取更多信息
Великобритания констатировала упаднические настроения в Европе на фоне американской позиции по НАТО02:03